ARYLPIPERAZINES AND THEIR USE AS METALLOPROTEINASE INHIBITING AGENTS (MMP)
申请人:AstraZeneca AB
公开号:EP1109787B1
公开(公告)日:2006-05-17
US6734184B1
申请人:——
公开号:US6734184B1
公开(公告)日:2004-05-11
US7342020B2
申请人:——
公开号:US7342020B2
公开(公告)日:2008-03-11
[EN] ARYLPIPERAZINES AND THEIR USE AS METALLOPROTEINASE INHIBITING AGENTS (MMP)<br/>[FR] ARYLPIPERAZINES ET LEUR EMPLOI COMME INHIBITEURS DES METALLOPROTEINASES
申请人:ZENECA LTD
公开号:WO2000012478A1
公开(公告)日:2000-03-09
Arylpiperazines of formula (I) useful as metalloproteinase inhibitors, especially as inhibitors of MMP 13.
Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP)
申请人:AstraZeneca AB
公开号:US06734184B1
公开(公告)日:2004-05-11
Arylpiperazines of formula (I) useful as metalloproteinase inhibitors, especially as inhibitors of MMP 13.